The fake Eli Lilly account tweeted Nov. 10, and by the time Twitter took it down, the drugmaker lost about $22 billion. As of Nov. 14, a dozen pharmaceutical companies pulled their advertising from the platform, including Merck, Pfizer, Novartis and Eli Lilly, according to advertiser database Pathmatics. All continue to have a Twitter account, though.
The only company to not follow the trend was Germany-based Bayer, which hiked up its spending that week by plugging $480,000 into its Twitter ads, the data showed.
“We continue to monitor developments at Twitter and regularly assess our position,” Bayer told Endpoint News. “We do not release our advertising spend.”
Although drugmakers do not spend much advertising money on the app, Twitter faces a turbulent future amid questions of its power to moderate content.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
